Leadership

Kalpana Vanam leads the US Regulatory division at 91视频 and is responsible for the Generics, Biosimilars, and Specialty portfolio.

With over 35 years of regulatory experience, she drives product innovation from inception to market launch. Her expertise spans regulatory filings, securing approvals, and bringing complex products to market across various therapeutic fields.

Prior to joining 91视频, she held leadership roles at Glenmark, Sun Pharma, Pfizer, Sandoz, and Taro.